A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents - PubMed (original) (raw)

A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents

R A Schwendener et al. Invest Radiol. 1990 Aug.

Abstract

Small unilamellar liposomes that contain the lipophilic chelate DTPA-stearate (DTPASA) were used as carriers for the paramagnetic metal ions gadolinium, manganese, and iron. The iron liposomes were unstable in vitro and thus not studied further. The natural targeting properties of these liposomes to the reticuloendothelial system was used in rats and dogs for the imaging of liver and spleen. In vitro incubations with human plasma, followed by high-pressure liquid chromatography (HPLC) separation of the Gd-DTPASA and Mn-DTPASA liposomes showed that after an incubation period of 24 hours, only 4% of the gadolinium was bound to the plasma proteins, whereas, with the Mn-DTPASA liposomes, a transfer of 40% manganese was seen. These results indicate that the Mn-DTPASA complex is not stable. On T1-weighted images, both liposome preparations gave a strong signal enhancement of the organs of the mononuclear phagocyte system (MPS). Gadolinium liposomes accumulated in the liver of rats at a peak concentration 4 hours after application and at a higher concentration compared with the manganese liposomes. Gd-DTPASA liposomes had an elimination half-time from the liver of 61 hours. Manganese liposomes produced stronger contrast at lower concentrations and had faster elimination kinetics from the liver, with a major elimination half-time of 10 hours. Both chelate complexes were eliminated predominantly by the hepatobiliary route. Thus, liposomal Gd-DTPASA appears to be a stable, efficient, and specific magnetic resonance imaging (MRI) contrast agent for the upper abdomen.

PubMed Disclaimer

Cited by

Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP. Torchilin VP. AAPS J. 2007 May 11;9(2):E128-47. doi: 10.1208/aapsj0902015. AAPS J. 2007. PMID: 17614355 Free PMC article. Review.
Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.
Abozeid SM, Chowdhury MSI, Asik D, Spernyak JA, Morrow JR. Abozeid SM, et al. ACS Appl Bio Mater. 2021 Nov 15;4(11):7951-7960. doi: 10.1021/acsabm.1c00879. Epub 2021 Oct 15. ACS Appl Bio Mater. 2021. PMID: 35006776 Free PMC article.
Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques.
Tashjian JA, Dewhirst MW, Needham D, Viglianti BL. Tashjian JA, et al. Int J Hyperthermia. 2008 Feb;24(1):79-90. doi: 10.1080/02656730701840147. Int J Hyperthermia. 2008. PMID: 18214771 Free PMC article. Review.
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205. doi: 10.1007/s00259-006-0139-x. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763815
Imaging and drug delivery using theranostic nanoparticles.
Janib SM, Moses AS, MacKay JA. Janib SM, et al. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1052-1063. doi: 10.1016/j.addr.2010.08.004. Epub 2010 Aug 13. Adv Drug Deliv Rev. 2010. PMID: 20709124 Free PMC article. Review.

A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents - PubMed (original) (raw)